Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cellular macromolecules in exposed tissue refers to the collective group of essential biological polymers—including DNA, RNA, proteins, and lipids—that serve as the primary targets for reactive chemical agents and ionizing radiation in tissues directly contacted by these stressors. This concept is central to the toxicology of vesicants like sulfur mustard and nitrogen mustard, which act as potent bifunctional alkylating agents. These agents form highly reactive electrophilic intermediates that covalently bind to nucleophilic sites on cellular macromolecules, most notably the N7 position of guanine in DNA, leading to the formation of adducts and interstrand cross-links. Such modifications disrupt critical cellular processes, including DNA replication and protein synthesis, triggering signaling cascades that lead to cell cycle arrest, apoptosis, and the characteristic inflammatory blistering (vesication) of the skin, eyes, and respiratory tract. In addition to their role in toxicity, these macromolecules are the therapeutic targets for nitrogen mustard-derived chemotherapeutic drugs, such as mechlorethamine, which exploit the same alkylating mechanism to induce lethal DNA damage in cancer cells. Protective and therapeutic strategies against macromolecular damage include the use of nucleophilic scavengers like sodium thiosulfate to neutralize agents before they react, as well as antioxidants like N-acetylcysteine to mitigate secondary oxidative damage.
Alkylation of nucleophilic sites in DNA, proteins, and lipids; formation of DNA interstrand cross-links; induction of oxidative stress and lipid peroxidation; depletion of cellular glutathione.
11 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cellular macromolecules in exposed tissue.